OK
The Universal Selection Source:
Adhesives Ingredients
Industry News

UPM Raflatac to Discuss Advanced Labeling Solutions for Healthcare Market at Pharmapack 2018

Published on 2018-02-05. Author : SpecialChem

UPM Raflatac’s pharmaceutical and healthcare labeling experts will be present at Pharmapack exhibition on 7-8 February 2018 in Paris, France. Visitors on stand B18 will have the opportunity to see and discuss labeling solutions specified for the latest pharmaceutical and healthcare market needs.


Pharmapack 2018

Highlights at Pharmapack 2018


  • UPM Raflatac will be focusing on a labeling range which supports compliance with the Falsified Medicines Directive (2011/62/EU) regarding packaging for prescription drugs and high-risk, over-the-counter medicines. An estimated 30 billion such packs issued annually are affected in the EU. The deadline for compliance is coming up soon, already on February 9, 2019 in majority of the EU member states.
  • The RP62 EU and RP62 EUL adhesives, supplied with tamper-verification labeling products, create a tear on the typically used cardboard cartons. The RP62 EUL adhesive also has luminescent characteristics for detecting missing labels. Both adhesives are available with a range of clear film as well as paper-based label faces supporting legislative requirements for individually authenticated, tamper-evident packs which protect the supply chain from counterfeits.
  • Another highlight is UPM Raflatac’s new labeling solution for the medical device segment. The RPMD adhesive range is specially designed for different medical device sub-segments such as sterilization wraps and bags, infusion bags and bottles, drug-device combinations like pens, auto-injectors and inhalers and blood donation labeling. Selected paper and film face materials, combined with a new multi-faceted RPMD adhesive, have excellent adhesion with a tight mandrel hold on glass and plastic, and are both sterilization resistant and migration safe. RPMD is fully compliant with the recent EU Medical Devices and In Vitro Diagnostic Regulations.


Source: UPM Raflatac
FEICA 2018 European Adhesive and Sealant Conference and EXPO
Back to Top